期刊文献+

脐血造血干细胞移植治疗血液病的应用研究进展 被引量:1

原文传递
导出
摘要 脐血是胎儿娩出、脐带结扎并离断后残留在胎盘和脐带中的血液,通常是废弃不用的。研究发现,脐血造血干细胞移植是利用脐带血中造血干细胞重建造血和免疫系统的一种治疗方法。脐血来源丰富,获取方便,
出处 《中国输血杂志》 CAS CSCD 北大核心 2012年第3期283-285,共3页 Chinese Journal of Blood Transfusion
  • 相关文献

参考文献23

  • 1Gluckman E.Ten years of cord blood transplantation:from bench tobedside.Br J Haematol 2009,147(2):192-199.
  • 2Delaney C,Ratajczak MZ,Laughlin MJ.Strategies to enhance um-bilical cord blood stem cell engraftment in adult patients.ExpertRev Hematol,2010,3(3):273-283.
  • 3Eapen M,Rubinstein P,Zhang MJ,et al.Outcomes of transplanta-tion of unrelated donor umbilical cord blood and bone marrow inchildren with acute leukaemia:a comparison study.Lancet,2007,369(9577):1947-1954.
  • 4Sanz J,Sanz MA,Saavedra S,et al.Cord blood transplantation fromunrelated donors in adults with high-risk acute myeloid leukemia.Biol Blood Marrow Transplant,2010,16(1):86-94.
  • 5Bachanova V,Verneris MR,DeFor T,et al.Prolonged survival in a-dults with acute lymphoblastic leukemia after reduced-intensityconditioning with cord blood or sibling donor transplantation.Blood,2009,113(13):2902-2905.
  • 6Rocha V,Wagner JE,Sobocinski KA,et al.Graft-versus-host dis-ease in children who have received a cord blood or bone marrowtransplant from an HLA-identical sibling.N Engl J Med,2000,342(25):1846-1854.
  • 7Sanz J,Montesinos P,Saavedra S,et al.Single-unit umbilical cordblood transplantation form unrelated donors in adult patients withchronic myelogenous leukemia.Biol Blood Marrow Transplant,2010,16(11):1589-1595.
  • 8刘利,刘强,郝淼旺,陈任安,蒋姗姗,张继良,王黎红,何华,吴绒丽,杜娟,叶盛开,尹单单,梁英民.非清髓单倍体造血干细胞移植联合格列卫治疗慢性粒细胞白血病[J].临床血液学杂志,2006,19(1):3-6. 被引量:10
  • 9Tomblyn M,Brunstein C,Burns LJet al.Similar and promising out-comes in lymphoma patients treated with myeloablative or nonmye-loablative conditioning and allogeneic hematopoietic cell transplan-tation.Biol Blood Marrow Transplant,2008,14(5):538-545.
  • 10Brunstein CG,Cantero S,Cao Q,et al.Promising progression-freesurvival for patients low and intermediate grade lymphoid malignan-cies after nonmyeloablative unbilical cord blood transplantation.Bi-ol Blood Marrow Transplant,2009,15(2):214-222.

二级参考文献9

  • 1Wadhwa J, Szydlo R M, Apperley J F, et al. Factors affecting duration of survival after onset of blastic trans-formation of chronic myeloid leukemia. Blood, 2002,99:2304-2309.
  • 2Deininger M W, Golderman J M, Lydon N, et al. The tyrosine kinase inhibitor CGP571 48B selectively inhibits the growth of BCR-ABL positive cells. Blood, 1997,90:3691-3698.
  • 3Champlin R, Khouri I, Shimoni A, et al. Harnessing graft versus-malignancy: Non-myeloablative preparative regimens for allogeneic haematopoietic transplantation,an evolving strategy for adoptive immunotherapy. Br J Haematol, 2000, 111:18-29.
  • 4Baker M B, Altman N H, Podack E R, et al. The role of cell-mediated cytotoxicity in acute GVHD after MHC-mediatedbone marrow transplantation in mice.JExp Med, 1996, 183:2645-2656.
  • 5Harris D T, Sakiestewa D, Lyons C, et al. Prevention ofgraft-versus-host disease (GVHD) by elimination of recipi-ent-reactive donor T cells with recombinanttoxins thattargetthe interleukin2 (IL-2) receptor. Bone Marrow Transplantation, 1999, 23:137-144.
  • 6Druker B J. Imatinib Alone and in Combination for Chronic Myeloid Leukemia. Seminars in Hematology,2003, 40:50-58.
  • 7Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem ceil transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood, 1998,91:756-763.
  • 8Druker B J, Talpaz M, Resta D J, et al. Effcacy and safety of a speci, c inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med,2001, 344:1031-1037.
  • 9梁辉,王昀,邓晓辉,郭若冰,马静秋,陈文娟,余金妹.无关供体非清髓性干细胞移植治疗慢性粒细胞白血病1例[J].临床血液学杂志,2002,15(4):175-177. 被引量:1

共引文献9

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部